Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts

The Journal of Clinical Investigation
R CiubotariuN Suciu-Foca

Abstract

The role of the indirect allorecognition pathway in acute allograft rejection has been documented both in organ recipients and in experimental models. However, it is unknown whether self-restricted recognition of donor alloantigens also contributes to chronic allograft rejection. The aim of this study was to determine the relationship between allopeptide reactivity, epitope spreading, and chronic rejection. Using synthetic peptides corresponding to the hypervariable region of 32 HLA-DR alleles, we have followed the specificity of self-restricted T cell alloresponses to the donor in a population of 34 heart allograft recipients. T cells from sequential samples of blood collected from the patients up to 36 mo after transplantation were studied in limiting dilution analysis for allopeptide reactivity. The incidence of coronary artery vasculopathy (CAV) was significantly higher in patients who displayed persistent alloreactivity late after transplantation than in patients who showed no alloreactivity after the first 6 mo after transplantation. Both intra- and intermolecular spreading of epitopes was observed with an increased frequency in patients developing CAV in less than 2 yr, compared with patients without CAV; this suggests t...Continue Reading

References

Sep 1, 1992·The Clinical Investigator·P HäyryT Paavonen
Apr 1, 1991·Immunology Today·E Sercarz, U Krzych
Mar 1, 1991·Transplantation·N Suciu-FocaD W King
Mar 1, 1990·Immunology Today·R I LechlerF H Bach
Nov 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J ThybergB A Bottger
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M K JenkinsR H Schwartz
Dec 1, 1987·Cellular Immunology·M YoshikawaN Hozumi
Apr 11, 1985·Nature·A Lanzavecchia
Sep 1, 1987·The Annals of Thoracic Surgery·W H FristN E Shumway
Jan 1, 1993·Annual Review of Immunology·E E SercarzK Moudgil
May 1, 1993·Immunology Today·P V LehmannG Gammon
Apr 1, 1993·Immunology Today·M J Mamula, C A Janeway
Mar 1, 1996·Clinical Immunology and Immunopathology·Z LiuN Suciu-Foca
Jan 1, 1996·International Reviews of Immunology·A I ColovaiN Suciu-Foca
Jan 1, 1996·International Reviews of Immunology·M H Sayegh, C B Carpenter
Jan 1, 1996·International Reviews of Immunology·G Benichou, E V Fedoseyeva
Jan 1, 1996·International Reviews of Immunology·J A Bradley
Sep 1, 1996·The Journal of Clinical Investigation·Z LiuN Suciu-Foca
Dec 1, 1996·Current Opinion in Immunology·C J Vanderlugt, S D Miller
Oct 27, 1997·Transplantation·S TuguleaN Suciu-Foca

❮ Previous
Next ❯

Citations

Nov 15, 2002·International Journal of Hematology·Richard K BurtAlberto M Marmont
Sep 16, 2004·Transplant International : Official Journal of the European Society for Organ Transplantation·Marcus D SäemannGerhard J Zlabinger
Feb 16, 2005·Transplant International : Official Journal of the European Society for Organ Transplantation·Angélique BrossayHervé Watier
Jan 1, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Elizabeth Ingulli
Oct 8, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Emilio D PoggioPeter S Heeger
Mar 27, 2001·Transplantation Proceedings·L FrascaG Lombardi
Mar 27, 2001·Transplantation Proceedings·R S LeeJ C Madsen
Mar 27, 2001·Transplantation Proceedings·M Spadafora-FerreiraV Coelho
Mar 27, 2001·Transplantation Proceedings·A Iniotaki-TheodorakiC Stavropoulos-Giokas
Mar 27, 2001·Transplantation Proceedings·E Renna MolajoniR Cortesini
Mar 27, 2001·Transplantation Proceedings·R CiubotariuN Suciu Foca Cortesini
Dec 26, 2001·Transplantation Proceedings·G J PettigrewJ A Bradley
Dec 26, 2001·Transplantation Proceedings·H K RollsE V Fedoseyeva
Sep 2, 1998·Transplantation Proceedings·C C Magee, M H Sayegh
Mar 20, 1999·Transplantation Proceedings·N Suciu-FocaR Cortesini
Mar 20, 1999·Transplantation Proceedings·A Iniotaki-TheodorakiA Kostakis
Feb 13, 2001·Human Immunology·R CiubotariuN Suciu-Foca Cortesini
Oct 24, 2002·Human Immunology·Raffaello CortesiniNicole Suciu-Foca Cortesini
Oct 9, 2002·Human Immunology·Ana Gabriela SitaruChristoph Otto
Oct 3, 1998·Human Immunology·G BenichouE V Fedoseyeva
Sep 28, 2000·Current Opinion in Immunology·A M WaagaN L Tilney
Sep 10, 2002·Transplant Immunology·David S Game, Robert I Lechler
Sep 10, 2002·Transplant Immunology·Frans H J Claas
Jun 12, 2003·Transplant Immunology·Michel P M VierboomMargreet Jonker
Jan 18, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Kim C LuT Mohanakumar
Jul 5, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Philip F Halloran
Mar 26, 2002·Nature Reviews. Immunology·Carol L Vanderlugt, Stephen D Miller
Jul 12, 2002·Kidney International·Joana E Kist-van HoltheAna Maria Waaga
Jun 19, 1998·The New England Journal of Medicine·M H Sayegh, L A Turka
Dec 24, 2004·The New England Journal of Medicine·Mohamed H Sayegh, Charles B Carpenter
Nov 11, 1999·The American Journal of Surgical Pathology·K BlakolmerA Demetris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.